Kyverna Therapeutics Inc (NASDAQ:KYTX) price is hovering higher on current market day and jumping 21.27% above its previous close.
A look at today’s price movement shows that the recent level at last check reads $5.77, with intraday deals fluctuating between $5.955 and $7.2. Taking into account the 52-week price action we note that the stock hit a 52-week high of $35.06 and 52-week low of $3.92. The stock added 46.39% on its value in the past month.
Kyverna Therapeutics Inc, which has a market valuation of $321.01 million, is expected to release its quarterly earnings report in January.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give KYTX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Sell.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned KYTX a recommendation rating as follows: 1 rate it as a Hold; 0 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Kyverna Therapeutics Inc (KYTX) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Hold, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that KYTX’s price is at present 39.61% off the SMA20 and 38.13% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 72.74, with weekly volatility standing at 12.86%. The indicator jumps to 9.15% when calculated based on the past 30 days. Kyverna Therapeutics Inc (NASDAQ:KYTX)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.53.
An analysis of the Kyverna Therapeutics Inc (NASDAQ:KYTX) stock in terms of its daily trading volume indicates that the 3-month average is 338.49K. However, this figure increases on the past 10-day timeline to an average of 0.35 million.
Current records show that the company has 43.17M in outstanding shares. The insiders’ percentage holdings are 56.68% of outstanding shares while the percentage share held by institutions stands at 31.25%. The stats also highlight that short interest as of 2024-11-15, stood at 2.32 million shares, which puts the short ratio at the time at 9.29. From this we can glean that short interest is 698.00 of company’s current outstanding shares. Notably, we see that shares short in November fall slightly given the previous month’s figure stood at 2.49 million. But the -76.68% downside, the stock’s price has registered year-to-date as of today’s value, will likely reignite investor interest given the prospect of it rallying even higher.
